Goodwin, Latham Steer $2.8B Drug Discovery SPAC Deal

By Emma Whitford · June 9, 2021, 5:52 PM EDT

Boston-based drug discovery startup Valo Health LLC said Wednesday that it plans to go public at a valuation of about $2.8 billion through a merger with a blank check company, in...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Emma

January 12, 2022
Cooley, Loeb & Loeb Shape $511M Medical Co. SPAC Merger
October 01, 2021
Merck Accuses Bayer Of Ducking Product Liability Claims
September 03, 2021
No Excuse To Delay Discovery, Mallinckrodt Claimants Say
August 13, 2021
VA Must Face Construction Co. Claims Despite Naming Error
July 16, 2021
Kirkland Guides Shore Capital Funds Totaling $686M
July 12, 2021
Weil, DLA Piper Rep $32.6B SPAC Deal For MSP Recovery
May 25, 2021
Cooley Steers Weight Loss Co. Noom's $540M Series F Round
May 19, 2021
Texas Health Tech Startup Wheel Raises $50M Series B
May 07, 2021
Skadden, Davis Polk Lead Chinese Insurance Co.'s $360M IPO
March 29, 2021
CDC Extends Federal Anti-Eviction Order Through June